ATE421693T1 - Proteine in der diabetes-proteomanalyse - Google Patents

Proteine in der diabetes-proteomanalyse

Info

Publication number
ATE421693T1
ATE421693T1 AT02742845T AT02742845T ATE421693T1 AT E421693 T1 ATE421693 T1 AT E421693T1 AT 02742845 T AT02742845 T AT 02742845T AT 02742845 T AT02742845 T AT 02742845T AT E421693 T1 ATE421693 T1 AT E421693T1
Authority
AT
Austria
Prior art keywords
diabetes
proteom
proteins
analysis
human
Prior art date
Application number
AT02742845T
Other languages
English (en)
Inventor
Peter Larsen
Stephen Fey
Joern Nerup
Allan Karlsen
Karin Nielsen
Original Assignee
Pride Proteomics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pride Proteomics As filed Critical Pride Proteomics As
Application granted granted Critical
Publication of ATE421693T1 publication Critical patent/ATE421693T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02742845T 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse ATE421693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100852 2001-05-29

Publications (1)

Publication Number Publication Date
ATE421693T1 true ATE421693T1 (de) 2009-02-15

Family

ID=8160539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742845T ATE421693T1 (de) 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse

Country Status (4)

Country Link
EP (2) EP2161578A1 (de)
AT (1) ATE421693T1 (de)
DE (1) DE60230988D1 (de)
WO (1) WO2002097434A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856708A (zh) * 2002-03-20 2006-11-01 普赖德普罗特奥米克斯公司 人糖尿病介导蛋白
CA2513317A1 (en) * 2004-07-06 2006-01-06 Kuhnil Pharmaceutical Co., Ltd. Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
EP2001875A2 (de) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase-aktivatoren
EP2049518B1 (de) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5407098A (en) * 1996-10-25 1998-05-29 Henrik U. Andersen Diabetes-mediating proteins and therapeutic uses thereof
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
EA005140B1 (ru) * 1999-04-02 2004-12-30 Корикса Корпорейшн Соединения и способы для лечения и диагностики рака легкого
AU783188B2 (en) * 1999-06-01 2005-10-06 Proteome Sciences Plc Method and compositions relating to insulin resistance disorders
GB9914890D0 (en) * 1999-06-25 1999-08-25 Univ Buckingham Methods and compositions relating to pancreatic islet and -cell dysfunction

Also Published As

Publication number Publication date
EP2161578A1 (de) 2010-03-10
DE60230988D1 (de) 2009-03-12
EP1402257A1 (de) 2004-03-31
EP1402257B1 (de) 2009-01-21
WO2002097434A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
ATE283485T1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
DK221090D0 (da) Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
ATE520026T1 (de) Sequenzielle analyse biologischer proben
DE69733560D1 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE496294T1 (de) Analyseset mit stechhilfe und messgerät
SE8802944L (sv) Material foer lapptestning
NO953770L (no) Analysemetode
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE520033T1 (de) Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen
DE59911255D1 (de) ELISPOT-Verfahren zur Quantifizierung der Aktivität von menschlichen und tierischen Zellen, zur insbesondere Blutzellen
EP1560025A3 (de) Marker spezifisch für Diabetes
WO2002066982A8 (de) Analyse von modifizierungen und demodifizierungen von proteinen mit ubiquintin-verwandten proteinen mittels fret (fluorescence resonance energy transfer)
WO2005119209A3 (en) System and method for analyzing microbial growth
DK0878715T3 (da) Cyanidholdig hæmoglobinreagenssammensætning og fremgangsmåder, som giver acceptabel præcision, nøjagtighed og frihed for interferens fra hvide blodlegemer på automatiserede hæmatologi-analysatorer
DE59710505D1 (de) Verwendung von tiefgefrorenem Blut für biologische Untersuchungsverfahren
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika
BRPI0515346A (pt) associação de polimorfismos protéicos com doenças coronárias do coração
DE60018063D1 (de) Platform für chemische und biologische analyse mit mikrowaage, analysegerät und verfahren zur verwendung derselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties